Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 235

1.

Application of antimicrobial stewardship to optimise management of community acquired pneumonia.

Bosso JA, Drew RH.

Int J Clin Pract. 2011 Jul;65(7):775-83. doi: 10.1111/j.1742-1241.2011.02704.x. Review.

PMID:
21676120
2.

Adherence to guidelines for community-acquired pneumonia: does it decrease cost of care?

Brown PD.

Pharmacoeconomics. 2004;22(7):413-20. Review.

PMID:
15137880
3.

Community acquired bacterial pneumonia.

Anevlavis S, Bouros D.

Expert Opin Pharmacother. 2010 Feb;11(3):361-74. doi: 10.1517/14656560903508770. Review.

PMID:
20085502
4.

Effectiveness of antimicrobial guidelines for community-acquired pneumonia in children.

Smith MJ, Kong M, Cambon A, Woods CR.

Pediatrics. 2012 May;129(5):e1326-33. doi: 10.1542/peds.2011-2412. Epub 2012 Apr 9.

PMID:
22492769
5.

Improving outcomes in elderly patients with community-acquired pneumonia by adhering to national guidelines: Community-Acquired Pneumonia Organization International cohort study results.

Arnold FW, LaJoie AS, Brock GN, Peyrani P, Rello J, Menéndez R, Lopardo G, Torres A, Rossi P, Ramirez JA; Community-Acquired Pneumonia Organization (CAPO) Investigators.

Arch Intern Med. 2009 Sep 14;169(16):1515-24. doi: 10.1001/archinternmed.2009.265.

PMID:
19752410
6.

Appropriate outpatient macrolide use in community-acquired pneumonia.

Gotfried MH.

J Am Acad Nurse Pract. 2004 Apr;16(4):146, 148, 150 passim. Review.

PMID:
15137473
7.

Antimicrobial stewardship in the management of community-acquired pneumonia.

Hurst JM, Bosso JA.

Curr Opin Infect Dis. 2013 Apr;26(2):184-8. doi: 10.1097/QCO.0b013e32835d0a8f. Review.

PMID:
23434896
8.

Guideline-concordant antibiotic use and survival among patients with community-acquired pneumonia admitted to the intensive care unit.

Frei CR, Attridge RT, Mortensen EM, Restrepo MI, Yu Y, Oramasionwu CU, Ruiz JL, Burgess DS.

Clin Ther. 2010 Feb;32(2):293-9. doi: 10.1016/j.clinthera.2010.02.006.

PMID:
20206787
9.

The impact of guidelines on the outcomes of community-acquired and ventilator-associated pneumonia.

Ferrer M, Menendez R, Amaro R, Torres A.

Clin Chest Med. 2011 Sep;32(3):491-505. doi: 10.1016/j.ccm.2011.06.002. Review.

PMID:
21867818
10.

[Accordance to guidelines for community acquired pneumonia in Europe and in the world].

Giejło M, Szmidt M.

Pneumonol Alergol Pol. 2007;75(2):173-9. Review. Polish.

PMID:
17973225
11.

Cost-effectiveness of empirical prescribing of antimicrobials in community-acquired pneumonia in three countries in the presence of resistance.

Martin M, Quilici S, File T, Garau J, Kureishi A, Kubin M.

J Antimicrob Chemother. 2007 May;59(5):977-89. Epub 2007 Mar 29.

PMID:
17395688
12.

Antimicrobial stewardship.

Fishman N.

Am J Infect Control. 2006 Jun;34(5 Suppl 1):S55-63; discussion S64-73.

PMID:
16813983
13.

How good is the evidence for the recommended empirical antimicrobial treatment of patients hospitalized because of community-acquired pneumonia? A systematic review.

Oosterheert JJ, Bonten MJ, Hak E, Schneider MM, Hoepelman IM.

J Antimicrob Chemother. 2003 Oct;52(4):555-63. Epub 2003 Sep 12. Review.

PMID:
12972448
14.

Improving outcomes of elderly patients with community-acquired pneumonia.

Gutiérrez F, Masiá M.

Drugs Aging. 2008;25(7):585-610. Review.

PMID:
18582147
16.

Experiences at a large teaching hospital with levofloxacin for the treatment of community-acquired pneumonia.

Clark LC, Davis CW.

Am J Health Syst Pharm. 2000 Nov 15;57 Suppl 3:S10-3.

PMID:
11098314
17.

Impact of a guideline on management of children hospitalized with community-acquired pneumonia.

Newman RE, Hedican EB, Herigon JC, Williams DD, Williams AR, Newland JG.

Pediatrics. 2012 Mar;129(3):e597-604. doi: 10.1542/peds.2011-1533. Epub 2012 Feb 20.

PMID:
22351891
18.

What is the role of antimicrobial stewardship in improving outcomes of patients with CAP?

Nussenblatt V, Avdic E, Cosgrove S.

Infect Dis Clin North Am. 2013 Mar;27(1):211-28. doi: 10.1016/j.idc.2012.11.008. Review.

PMID:
23398876
19.

Implementing a pharmacist-led sequential antimicrobial therapy strategy: a controlled before-and-after study.

Dunn K, O'Reilly A, Silke B, Rogers T, Bergin C.

Int J Clin Pharm. 2011 Apr;33(2):208-14. doi: 10.1007/s11096-010-9475-9. Epub 2011 Jan 25.

PMID:
21744190
20.

Evidence for moxifloxacin in community-acquired pneumonia: the impact of pharmaco-economic considerations on guidelines.

Simoens S.

Curr Med Res Opin. 2009 Oct;25(10):2447-57. doi: 10.1185/03007990903223663. Review.

PMID:
19678752

Supplemental Content

Support Center